The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCostain Regulatory News (COST)

Share Price Information for Costain (COST)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 83.00
Bid: 82.80
Ask: 84.20
Change: -1.80 (-2.12%)
Spread: 1.40 (1.691%)
Open: 83.20
High: 84.00
Low: 83.00
Prev. Close: 84.80
COST Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

A303 Delivery Assurance Partnership

30 Sep 2022 14:32

RNS Number : 4010B
Costain Group PLC
30 September 2022
 

 

Costain Group PLC

30 September 2022

 

 

Costain Joint Venture Wins A303 Delivery Assurance Partnership

 

Costain announces that National Highways has appointed a Costain and Mott MacDonald joint venture as Delivery Assurance Partner for the A303 Stonehenge Improvements Scheme. In this consultancy role, Costain and its partner will manage the design and construction by the main contractor of a new dual carriageway and tunnel, replacing the existing single carriage road. 

 

The joint venture, as part of the National Highways integrated project team, will collaborate with the customer, main contractor, supply chain, road users and the local community to ensure the effective design and delivery of the A303 improvement works.

 

Sue Kershaw, managing director for Transportation, Costain, commented:"This award demonstrates Costain's growing consultancy position as an established delivery assurance partner; where together with our customers we will be creating connected, sustainable infrastructure that helps people and the planet to thrive. This is the second award for our Costain Mott MacDonald partnership and demonstrates the delivery of our strategy in meeting the wider needs of our customers."

 

Ken Norbury, transportation managing director, Mott MacDonald said: "We have assembled a world class multidisciplinary team to support the delivery of this vital upgrade project. We are proud to be chosen alongside Costain and look forward to working collaboratively with the project team."

 

Derek Parody, National Highways' Project Director for the A303 Stonehenge scheme, said: "We're pleased we have completed the procurement process, and once the redetermination process is finalised, and should the Development Consent Order be granted, having this expertise in place will put us in the strongest possible position to deliver this transformational scheme and deliver the benefits we know it can."

 

Once complete, the scheme will significantly improve the lives of people living in and travelling through the area, enhance the Stonehenge World Heritage site and the setting of the stones, while bringing economic and environmental benefits by reducing congestion and increasing biodiversity.

 

 

 

Enquiries

 

Investors and analysts

paul.sharma@costain.com

Paul Sharma

+44 (0) 7867 501188

 

 

Financial media - Headland

costain@headlandconsultancy.com

Andy Rivett-Carnac

+44 (0) 7968 997 365

 

Notes to editors

 

Costain helps to improve people's lives by creating connected, sustainable infrastructure that enables people and the planet thrive. We shape, create and deliver pioneering solutions that transform the performance of the infrastructure ecosystem across the UK's transport, energy, water, and defence markets.

 

We are organised around our customers anticipating and solving their challenges and helping to improve performance. By bringing together our unique mix of construction, consulting and digital experts we engineer and deliver sustainable, efficient and practical solutions.

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKKBBNBKDCCN
Date   Source Headline
29th Nov 20162:42 pmRNSProposed Placing
21st Nov 20167:00 amRNSContract
15th Nov 20167:00 amRNSContract
4th Nov 20161:48 pmRNSDirector/PDMR Shareholding
1st Nov 20169:37 amRNSTotal Voting Rights
31st Oct 20167:00 amRNSTotal Voting Rights
27th Oct 20167:00 amRNSBlock Listing Application
19th Oct 20164:36 pmRNSDividend Declaration - Amendment
18th Oct 20168:00 amRNSDividend - Scrip Alternative
27th Sep 201612:38 pmRNSDirector/PDMR Shareholding
23rd Sep 201611:06 amRNSHolding(s) in Company
22nd Sep 201611:43 amRNSScrip Dividend Reference Price
20th Sep 201612:57 pmRNSHolding(s) in Company
6th Sep 201612:11 pmRNSDirector/PDMR Shareholding
1st Sep 201612:13 pmRNSHolding(s) in Company
30th Aug 20164:28 pmRNSHolding(s) in Company
30th Aug 20164:08 pmRNSHolding(s) in Company
24th Aug 20167:00 amRNSHalf-year Report
11th Jul 201610:16 amRNSDirector Declaration
6th Jul 20167:00 amRNSAcquisition
30th Jun 201612:53 pmRNSDirector/PDMR Shareholding
30th Jun 20168:57 amRNSBlock listing Interim Review
30th Jun 20167:00 amRNSTrading Update
17th Jun 20167:00 amRNSBusiness Briefing
31st May 20169:00 amRNSTotal Voting Rights
17th May 20167:00 amRNSDividend - Scrip Alternative
16th May 20163:03 pmRNSDirector/PDMR Shareholding
5th May 20164:51 pmRNSResult of AGM
5th May 20167:01 amRNSLTIP Listing Application
5th May 20167:00 amRNSAGM Statement
25th Apr 20167:00 amRNSHolding(s) in Company
21st Apr 20162:05 pmRNSScrip Dividend Reference Price
18th Apr 201610:22 amRNSHolding(s) in Company
7th Apr 20167:00 amRNSDirector/PDMR Shareholding
6th Apr 20167:00 amRNSAppointment of Chairman Designate
4th Apr 201610:38 amRNSDirector/PDMR Shareholding
31st Mar 201610:32 amRNSNotice of AGM
2nd Mar 20167:00 amRNSFinal Results
1st Feb 20167:00 amRNSRe Contract
21st Jan 20169:07 amRNSHolding(s) in Company
11th Jan 20167:00 amRNSConfirmation of Contract Award
7th Jan 201612:17 pmRNSHolding(s) in Company
6th Jan 20167:00 amRNSTrading Update
4th Jan 20168:55 amRNSBlocklisting Interim Review
24th Dec 201512:17 pmRNSDirector/PDMR Shareholding
22nd Dec 201511:46 amRNSHolding(s) in Company
22nd Dec 20159:13 amRNSHolding(s) in Company
17th Dec 20157:00 amRNSRe Contract
9th Dec 201511:22 amRNSHolding(s) in Company
1st Dec 20159:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.